| |
| Signaling |
|
SIG-1
|
Ando, Hideya
(NCI)
|
H. Ando, K. Yasumoto, E. Costin, H. Watabe, V.J. Hearing
|
| |
Regulation of the Ubiquitin-Proteasome Pathway by Fatty Acids
|
| |
|
SIG-2
|
Boland, Genevieve
Marie (NIAMS)
|
G. Boland, D. Hall, R. Tuan
|
| |
Signaling Crosstalk Through TGF-betas and IGFs During Adult Human Mesenchymal Stem Cell Chondrogenesis
|
| |
|
SIG-3
|
Burke, Terrence
(NCI)
|
T. R. Burke, Jr.,Y Gao, C.-Q. Wei, X. Wang, K. Lee, Z.-D. Shi and D. Yang
|
| |
Design, Synthesis and Biological Evaluation of Potent Grb2 SH2 Domain-Binding Antagonists as Potential New Anticancer Therapeutics
|
| |
|
SIG-4
|
Davis, Margaret
I (NIAAA)
|
M. I. Davis, S. R. Ikeda and D. M. Lovinger1
|
| |
Are Phosphatases Involved in Cannabinoid Receptor Signaling to ERK?
|
| |
|
SIG-5
|
Dykstra, Michelle
L (NIAID)
|
M.L. Dykstra and S.K. Pierce
|
| |
Sustained signaling accompanies BCR internalization to class II compartments
|
| |
|
SIG-6
|
Honse, Yumiko
(NIAAA)
|
Y. Honse, H. Ren, and R.W. Peoples
|
| |
Role of the NMDA Receptor NR2A Subunit M4 Domain in Ion Channel Gating and Alcohol Action
|
| |
|
SIG-7
|
Li, Peng
(NCI)
|
P. Li, M. Zhang, D. Yang, and P.P. Roller
|
| |
Potent Antagonists of the Grb2-SH2 Domain: Overall optimization of the Cyclic Peptide G1TE
|
| |
|
SIG-8
|
Liu, Qing-Rong
(NIDA)
|
Q.-R. Liu, P.-W. Zhang and G. R. Uhl
|
| |
KEPI and GCPI, Two Novel Members of PP1 Inhibitory Protein Activated by PKC
|
| |
|
SIG-9
|
Mitchell, Drake
C. (NIAAA)
|
DC Mitchell, BJ Litman
|
| |
Ethanol Enhances The Kinetics Of Receptor-G Protein Binding
|
| |
|
SIG-10
|
Nguyen, Dzung
H. (NIA)
|
D.H. Nguyen and D.D. Taub
|
| |
Inhibition of Chemokine Receptor Function by Microbial Cholesterol Oxidase and Sphingomyelinase
|
| |
|
SIG-11
|
Niu, Shui-Lin
(NIAAA)
|
S.L. Niu, D.C. Mitchell, S.Y. Lim, Z.M. Wen, H.Y. Kim, N. Salem, Jr., and B.J. Litman
|
| |
N-3 Deficiency in Rats Reduces G-protein Coupled Signal Transduction in Retinal Rod Outer Segment Membranes
|
| |
|
SIG-12
|
Robinson-White, Audrey
(NICHD)
|
A. Robinson-White, T.R. Hundley, and C.A. Stratakis
|
| |
Investigation of the MAP kinase Signal Pathway in PRKARIA-Mutant Cells
|
| |
|
SIG-13
|
Shi, Zhen-dan
(NCI)
|
Z.-D. Shi, M.C. Zhang, D.J. Yang, T. Burke. Jr. Laboratory of Medicinal Chemistry, NCI-Frederick and Department of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI
|
| |
Design and Synthesis of a Novel Macrocycle that Exhibits High Grb2 SH2 Domain-Binding Affinity
|
| |
|
SIG-14
|
Zhang, Xuan
(NIAMS)
|
X. Zhang, P. E. Lipsky, L. He, D. Shii, and A. C. Grammer
|
| |
CD40 Induced F-kB Activation in Human B Lymphocytes is mediated by diverse signaling Pathways
|
| |
|
SIG-15
|
Gong, Jianping
(NIDA)
|
J-P Gong*, Q.-R. Liu , Z Lin and G. Uhl. Mol. Neurobiol. Branch, NIDA-IRP, NIH Baltimore, MD 21224
|
| |
KEPI: a potential intermediate signal molecule between PKC and PP1 for the functional regulation of dopamine transporter
|
| |